The next generation of healthcare leaders must effectively advance care delivery through digital tools and modern workflows without compromising quality.
Wolters Kluwer is ready to support the next wave of healthcare professionals by uniting our decades-long devotion to providing rigorously validated, evidence-based content clinicians know they can trust with a forward-thinking commitment to digital and AI-powered innovations. We’re returning to the annual HIMSS conference to share our vision for how to set the standard for AI-powered decision support and workflow integration and to learn about your goals for the future of healthcare technology.
Setting the standard for AI: Clinically validated guidance and agent-ready structure
When it comes to AI use, healthcare has been one of the quicker industries to employ new technologies, adopting AI tools at more than twice the rate of other industries.
While there is a lot to be gained from AI-powered tools, it is essential for healthcare leaders and clinical users to understand the importance of AI validation and be confident in the tools they’re using. At HIMSS, our experts will be discussing AI validation and giving demonstrations of UpToDate® Expert AI, our purpose-built clinical AI solution. By integrating industry-leading, peer-reviewed content into AI-powered digital tools, every insight is grounded in the latest research and clinical best practices. This helps professionals throughout the healthcare ecosystem be confident they are relying on the same trusted evidence they have depended on for decades, while also benefiting from modern, intelligent experiences tailored to today’s care environments.
Also at HIMSS, we will debut, Medi-Span® Expert AI, built to support intelligent medication workflows in the AI era. To move medication workflows forward responsibly, healthcare leaders need a reliable foundation that combines trusted drug knowledge, regulatory awareness, and advanced decision logic — designed from the outset to support AI-driven applications. This foundation must deliver agent-ready content and tools that allow organizations to build medication workflows with confidence, knowing AI recommendations are grounded in industry-leading drug data and knowledge from Medi Span. Our newest Model Context Protocol service delivers the structured and clinically validated medication intelligence layer that AI agents need for appropriate medication decision-making.
